+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 143 Pages
  • June 2022
  • Region: Global
  • IMARC Group
  • ID: 5615024
The global anti-obesity drugs market reached a value of US$ 1.78 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 3.63 Billion by 2027, exhibiting a CAGR of 12.61% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.

Anti-Obesity Drugs Market Trends:


Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global anti-obesity drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, drug type and distribution channel.

Breakup by Drug Class:

  • Peripherally Acting Drugs
  • Centrally Acting Drugs

Breakup by Drug Type:

  • Prescription Drugs
  • OTC Drugs

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.

Key Questions Answered in This Report:

  • How has the global anti-obesity drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-obesity drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-obesity drugs market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Anti-Obesity Drugs Market

What is the estimated value of the Global Anti-Obesity Drugs Market?

The Global Anti-Obesity Drugs Market was estimated to be valued at $1.8 Billion in 2021.

What is the growth rate of the Global Anti-Obesity Drugs Market?

The growth rate of the Global Anti-Obesity Drugs Market is 12.6%, with an estimated value of $3.6 Billion by 2027.

What is the forecasted size of the Global Anti-Obesity Drugs Market?

The Global Anti-Obesity Drugs Market is estimated to be worth $3.6 Billion by 2027.

Who are the key companies in the Global Anti-Obesity Drugs Market?

Key companies in the Global Anti-Obesity Drugs Market include Dover Corporation, Flowserve Corporation, Graco Inc., Grundfos Holding A/S, Idex Corporation, Ingersoll, Rand Inc., Leak and LEWA GmbH.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anti-Obesity Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Peripherally Acting Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Centrally Acting Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Prescription Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 OTC Drugs
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boehringer Ingelheim International GmbH
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Currax Pharmaceuticals LLC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Gelesis
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 GlaxoSmithKline plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Merck & Co. Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Norgine B.V.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Novo Nordisk A/S
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Rhythm Pharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 SHIONOGI & Co. Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Vivus LLC
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2021
Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
Table 7: Global: Anti-Obesity Drugs Market: Key Players

Companies Mentioned

  • Dover Corporation
  • Flowserve Corporation
  • Graco Inc.
  • Grundfos Holding A/S
  • Idex Corporation
  • Ingersoll-Rand Inc.
  • Leak-Proof Pumps (I) Pvt. Ltd.
  • LEWA GmbH
  • Seepex GmbH
  • SPX Flow Inc.
  • Tapflo (Wuxi) Pumps Co. Ltd.
  • Verder International B.V.
  • Xylem Inc.
  • Yamada Corporation,

Methodology

Loading
LOADING...